P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar

M. Feldmann; M. -C. Asselin; S. Wang; A. McMahon; R. Hinz; J. Duncan; S. Sisodiya; M. Koepp

P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar

M. Feldmann, M. -C. Asselin, S. Wang, A. McMahon, R. Hinz, J. Duncan, S. Sisodiya, M. Koepp

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Article number	EP2234
Pages (from-to)	S158-S159
Number of pages	2
Journal	Journal of Neurology
Volume	261
Issue number	Supplement 1
Publication status	Published - 1 May 2014

Cite this

Feldmann, M., Asselin, M. .-C., Wang, S., McMahon, A., Hinz, R., Duncan, J., Sisodiya, S., & Koepp, M. (2014). P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar. Journal of Neurology, 261(Supplement 1), S158-S159. Article EP2234.

@article{329f8e6a9b4a45db871012459931a517,

title = "P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar",

author = "M. Feldmann and Asselin, {M. -C.} and S. Wang and A. McMahon and R. Hinz and J. Duncan and S. Sisodiya and M. Koepp",

note = "Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014",

year = "2014",

month = may,

day = "1",

language = "Undefined",

volume = "261",

pages = "S158--S159",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "Springer Nature",

number = "Supplement 1",

}

Feldmann, M, Asselin, M-C, Wang, S, McMahon, A , Hinz, R, Duncan, J, Sisodiya, S & Koepp, M 2014, 'P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar', Journal of Neurology, vol. 261, no. Supplement 1, EP2234, pp. S158-S159.

P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar. / Feldmann, M.; Asselin, M. -C.; Wang, S. et al.
In: Journal of Neurology, Vol. 261, No. Supplement 1, EP2234, 01.05.2014, p. S158-S159.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar

AU - Feldmann, M.

AU - Asselin, M. -C.

AU - Wang, S.

AU - McMahon, A.

AU - Hinz, R.

AU - Duncan, J.

AU - Sisodiya, S.

AU - Koepp, M.

N1 - Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014

PY - 2014/5/1

Y1 - 2014/5/1

M3 - Article

SN - 0340-5354

VL - 261

SP - S158-S159

JO - Journal of Neurology

JF - Journal of Neurology

IS - Supplement 1

M1 - EP2234

ER -